Zenas BioPharma Ownership | Who Owns Zenas BioPharma?


OverviewRevenueFinancialsChart

Zenas BioPharma Ownership Summary


Zenas BioPharma is owned by 81.34% institutional investors, 21.20% insiders. Nea management company is the largest institutional shareholder, holding 6.53% of ZBIO shares.

ZBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockZenas BioPharma81.34%21.20%-2.54%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company2.73M6.53%$26.49M
Novo2.25M5.37%$21.80M
Fairmount funds management1.89M4.52%$18.34M
Nvp associates1.84M4.39%$17.81M
Deerfield management company, l.p. (series c)1.56M3.73%$15.14M
Vivo capital1.18M2.83%$11.47M
Blackrock funding, inc. /de1.10M2.62%$10.62M
Arrowmark colorado1.09M2.61%$10.60M
Pivotal bioventure partners investment advisor779.04K1.86%$7.55M
Rock springs capital management lp640.47K1.53%$6.21M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nvp associates1.84M9.67%$17.81M
Pivotal bioventure partners investment advisor779.04K4.68%$7.55M
Fairmount funds management1.89M2.38%$18.34M
Nea management company2.73M1.99%$26.49M
Novo2.25M1.54%$21.80M
Sectoral asset management210.63K1.35%$2.04M
Superstring capital management lp111.61K1.28%$1.08M
Vivo capital1.18M1.17%$11.47M
Rock springs capital management lp640.47K0.39%$6.21M
Eversept partners, lp325.48K0.29%$3.15M

Top Buyers

HolderShares% AssetsChange
Sectoral asset management210.63K1.35%210.63K
Nea management company2.73M1.99%119.77K
Blackrock funding, inc. /de1.10M0.00%81.50K
Pivotal bioventure partners investment advisor779.04K4.68%42.40K
Novo2.25M1.54%35.03K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---744.03K
Rock springs capital management lp640.47K0.39%-238.20K
Millennium management---134.90K
Eversept partners, lp325.48K0.29%-120.11K
M&t bank---62.62K

New Positions

HolderShares% AssetsChangeValue
Sectoral asset management210.63K1.35%210.63K$2.04M
Alpine global management12.91K0.03%12.91K$125.07K
Quarry lp843.000.00%843.00$8.17K
Physician wealth advisors67.000.00%67.00$650.00
Clearstead advisors23.00-23.00$223.00

Sold Out

HolderChange
Mrp capital investments-35.00
Corebridge financial-7.53K
Stoneridge investment partners-10.96K
Two sigma investments, lp-17.05K
Gsa capital partners llp-31.76K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20257212.50%34,055,19122.15%811.83%4767.86%11-45.00%
Mar 31, 2025664.76%32,487,0833.18%7713.66%27-42.55%20233.33%
Dec 31, 20246448.84%31,696,95628.35%240.69%4811.63%6-
Sep 30, 202443-24,696,152-59-43---

Recent Insider Transactions


DateNameRoleActivityValue
Feb 07, 2025Xiao Ting-Buy$77.60K
Feb 18, 2025MOULDER LEON O JR Chief Executive OfficerBuy$166.75K
Feb 07, 2025Xiao Ting-Buy$77.60K
Dec 03, 2024MOULDER LEON O JR Chief Executive OfficerBuy$269.00K
Dec 04, 2024MOULDER LEON O JR Chief Executive OfficerBuy$449.10K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q12-
2024 Q44-

ZBIO Ownership FAQ


Who Owns Zenas BioPharma?

Zenas BioPharma shareholders are primarily institutional investors at 81.34%, followed by 21.20% insiders and -2.54% retail investors. The average institutional ownership in Zenas BioPharma's industry, Biotech Stocks , is 304.14%, which Zenas BioPharma falls below.

Who owns the most shares of Zenas BioPharma?

Zenas BioPharma’s largest shareholders are Nea management company (2.73M shares, 6.53%), Novo (2.25M shares, 5.37%), and Fairmount funds management (1.89M shares, 4.52%). Together, they hold 16.43% of Zenas BioPharma’s total shares outstanding.

Does Blackrock own Zenas BioPharma?

BlackRock is not among the top 10 institutional shareholders of Zenas BioPharma.

Who is Zenas BioPharma’s biggest shareholder by percentage of total assets invested?

Nvp associates is Zenas BioPharma’s biggest shareholder by percentage of total assets invested, with 9.67% of its assets in 1.84M Zenas BioPharma shares, valued at 17.81M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools